In this study, GM2 treatment reduced the relative abundance of Akkermansiaceae, which belongs to Verrucomicrobiota in PD mice, suggesting GM2 may protect the mucus layer by inhibiting the degradation of mucin. This evidence concerns the gene MUC5AC and Parkinson disease.